Teladoc Quarterly Revenue Exceeds $500 Million
Benefiting from COVID-19-related lockdowns that had people turning to telehealth solutions like Teladoc Health's (NYSE: TDOC), the company saw its growth accelerate in 2020. But concerns have surfaced about the telehealth specialist's long-term growth prospects following recent acquisitions. Many investors may be wondering: Could these acquisitions signal a low confidence in the company's long-term organic growth potential or do they represent truly synergic mergers that could strengthen Teladoc's business?
Based on a look at Teladoc's just-posted second-quarter results, the company's growth story appears to alive and well. Though there are notably some steep costs associated with the tech company's investments in growth opportunities.
Image source: Getty Images.
Source Fool.com
